 | • レポートコード：MRC2Q12-19137 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、インスリンアスパルトの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にインスリンアスパルトのグローバル市場のxxx％を占める「3Ml:300ユニット」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 インスリンアスパルトの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのインスリンアスパルト市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 インスリンアスパルトのグローバル主要プレイヤーには、Toho Pharmaceutical、Hisun Pharmaceutical、Federal Pharmaceuticals、Ganlee Pharmaceuticals、Novo Nordisk、Sanofiなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 インスリンアスパルト市場は、種類と用途によって区分されます。世界のインスリンアスパルト市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 3Ml:300ユニット、10Ml:1000ユニット 【用途別セグメント】 病院、診療所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - インスリンアスパルト製品概要 - 種類別市場（3Ml:300ユニット、10Ml:1000ユニット） - 用途別市場（病院、診療所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のインスリンアスパルト販売量予測2017-2028 - 世界のインスリンアスパルト売上予測2017-2028 - インスリンアスパルトの地域別販売量 - インスリンアスパルトの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別インスリンアスパルト販売量 - 主要メーカー別インスリンアスパルト売上 - 主要メーカー別インスリンアスパルト価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（3Ml:300ユニット、10Ml:1000ユニット） - インスリンアスパルトの種類別販売量 - インスリンアスパルトの種類別売上 - インスリンアスパルトの種類別価格 ・用途別市場規模（病院、診療所、その他） - インスリンアスパルトの用途別販売量 - インスリンアスパルトの用途別売上 - インスリンアスパルトの用途別価格 ・北米市場 - 北米のインスリンアスパルト市場規模（種類別、用途別） - 主要国別のインスリンアスパルト市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのインスリンアスパルト市場規模（種類別、用途別） - 主要国別のインスリンアスパルト市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のインスリンアスパルト市場規模（種類別、用途別） - 主要国別のインスリンアスパルト市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のインスリンアスパルト市場規模（種類別、用途別） - 主要国別のインスリンアスパルト市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのインスリンアスパルト市場規模（種類別、用途別） - 主要国別のインスリンアスパルト市場規模（トルコ、サウジアラビア） ・企業情報 Toho Pharmaceutical、Hisun Pharmaceutical、Federal Pharmaceuticals、Ganlee Pharmaceuticals、Novo Nordisk、Sanofi ・産業チェーン及び販売チャネル分析 - インスリンアスパルトの産業チェーン分析 - インスリンアスパルトの原材料 - インスリンアスパルトの生産プロセス - インスリンアスパルトの販売及びマーケティング - インスリンアスパルトの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - インスリンアスパルトの産業動向 - インスリンアスパルトのマーケットドライバー - インスリンアスパルトの課題 - インスリンアスパルトの阻害要因 ・主な調査結果 |
It is a modified type of medical insulin used to treat type 1 and type 2 diabetes
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Insulin Aspart is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Insulin Aspart is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Insulin Aspart is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Insulin Aspart include Toho Pharmaceutical, Hisun Pharmaceutical, Federal Pharmaceuticals, Ganlee Pharmaceuticals, Novo Nordisk and Sanofi, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Insulin Aspart manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Insulin Aspart market. Further, it explains the major drivers and regional dynamics of the global Insulin Aspart market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Toho Pharmaceutical
Hisun Pharmaceutical
Federal Pharmaceuticals
Ganlee Pharmaceuticals
Novo Nordisk
Sanofi
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by specification and by application segments based on sales, price, and value for the period 2017-2028.
Insulin Aspart Segment by Specification
3Ml: 300 Units
10Ml: 1000 Units
Insulin Aspart Segment by Application
Hospital
Clinic
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Insulin Aspart market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Insulin Aspart, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Insulin Aspart, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Insulin Aspart, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Insulin Aspart sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Insulin Aspart market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Insulin Aspart sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Toho Pharmaceutical, Hisun Pharmaceutical, Federal Pharmaceuticals, Ganlee Pharmaceuticals, Novo Nordisk and Sanofi, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Insulin Aspart in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Insulin Aspart manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by specification, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by specification, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by specification, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by specification, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by specification, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Insulin Aspart sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Insulin Aspart Product Introduction
1.2 Market by Specification
1.2.1 Global Insulin Aspart Market Size Growth Rate by Specification, 2017 VS 2021 VS 2028
1.2.2 3Ml: 300 Units
1.2.3 10Ml: 1000 Units
1.3 Market by Application
1.3.1 Global Insulin Aspart Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Insulin Aspart Sales Estimates and Forecasts 2017-2028
2.2 Global Insulin Aspart Revenue Estimates and Forecasts 2017-2028
2.3 Global Insulin Aspart Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Insulin Aspart Sales by Region
2.4.1 Global Insulin Aspart Sales by Region (2017-2022)
2.4.2 Global Sales Insulin Aspart by Region (2023-2028)
2.5 Global Insulin Aspart Revenue by Region
2.5.1 Global Insulin Aspart Revenue by Region (2017-2022)
2.5.2 Global Insulin Aspart Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Insulin Aspart Sales by Manufacturers
3.1.1 Global Top Insulin Aspart Manufacturers by Sales (2017-2022)
3.1.2 Global Insulin Aspart Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Insulin Aspart in 2021
3.2 Global Insulin Aspart Revenue by Manufacturers
3.2.1 Global Insulin Aspart Revenue by Manufacturers (2017-2022)
3.2.2 Global Insulin Aspart Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Insulin Aspart Revenue in 2021
3.3 Global Insulin Aspart Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Insulin Aspart Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Insulin Aspart Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Specification
4.1 Global Insulin Aspart Sales by Specification
4.1.1 Global Insulin Aspart Historical Sales by Specification (2017-2022)
4.1.2 Global Insulin Aspart Forecasted Sales by Specification (2023-2028)
4.1.3 Global Insulin Aspart Sales Market Share by Specification (2017-2028)
4.2 Global Insulin Aspart Revenue by Specification
4.2.1 Global Insulin Aspart Historical Revenue by Specification (2017-2022)
4.2.2 Global Insulin Aspart Forecasted Revenue by Specification (2023-2028)
4.2.3 Global Insulin Aspart Revenue Market Share by Specification (2017-2028)
4.3 Global Insulin Aspart Price by Specification
4.3.1 Global Insulin Aspart Price by Specification (2017-2022)
4.3.2 Global Insulin Aspart Price Forecast by Specification (2023-2028)
5 Market Size by Application
5.1 Global Insulin Aspart Sales by Application
5.1.1 Global Insulin Aspart Historical Sales by Application (2017-2022)
5.1.2 Global Insulin Aspart Forecasted Sales by Application (2023-2028)
5.1.3 Global Insulin Aspart Sales Market Share by Application (2017-2028)
5.2 Global Insulin Aspart Revenue by Application
5.2.1 Global Insulin Aspart Historical Revenue by Application (2017-2022)
5.2.2 Global Insulin Aspart Forecasted Revenue by Application (2023-2028)
5.2.3 Global Insulin Aspart Revenue Market Share by Application (2017-2028)
5.3 Global Insulin Aspart Price by Application
5.3.1 Global Insulin Aspart Price by Application (2017-2022)
5.3.2 Global Insulin Aspart Price Forecast by Application (2023-2028)
6 North America
6.1 North America Insulin Aspart Market Size by Specification
6.1.1 North America Insulin Aspart Sales by Specification (2017-2028)
6.1.2 North America Insulin Aspart Revenue by Specification (2017-2028)
6.2 North America Insulin Aspart Market Size by Application
6.2.1 North America Insulin Aspart Sales by Application (2017-2028)
6.2.2 North America Insulin Aspart Revenue by Application (2017-2028)
6.3 North America Insulin Aspart Market Size by Country
6.3.1 North America Insulin Aspart Sales by Country (2017-2028)
6.3.2 North America Insulin Aspart Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Insulin Aspart Market Size by Specification
7.1.1 Europe Insulin Aspart Sales by Specification (2017-2028)
7.1.2 Europe Insulin Aspart Revenue by Specification (2017-2028)
7.2 Europe Insulin Aspart Market Size by Application
7.2.1 Europe Insulin Aspart Sales by Application (2017-2028)
7.2.2 Europe Insulin Aspart Revenue by Application (2017-2028)
7.3 Europe Insulin Aspart Market Size by Country
7.3.1 Europe Insulin Aspart Sales by Country (2017-2028)
7.3.2 Europe Insulin Aspart Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Insulin Aspart Market Size by Specification
8.1.1 Asia Pacific Insulin Aspart Sales by Specification (2017-2028)
8.1.2 Asia Pacific Insulin Aspart Revenue by Specification (2017-2028)
8.2 Asia Pacific Insulin Aspart Market Size by Application
8.2.1 Asia Pacific Insulin Aspart Sales by Application (2017-2028)
8.2.2 Asia Pacific Insulin Aspart Revenue by Application (2017-2028)
8.3 Asia Pacific Insulin Aspart Market Size by Region
8.3.1 Asia Pacific Insulin Aspart Sales by Region (2017-2028)
8.3.2 Asia Pacific Insulin Aspart Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Insulin Aspart Market Size by Specification
9.1.1 Latin America Insulin Aspart Sales by Specification (2017-2028)
9.1.2 Latin America Insulin Aspart Revenue by Specification (2017-2028)
9.2 Latin America Insulin Aspart Market Size by Application
9.2.1 Latin America Insulin Aspart Sales by Application (2017-2028)
9.2.2 Latin America Insulin Aspart Revenue by Application (2017-2028)
9.3 Latin America Insulin Aspart Market Size by Country
9.3.1 Latin America Insulin Aspart Sales by Country (2017-2028)
9.3.2 Latin America Insulin Aspart Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Insulin Aspart Market Size by Specification
10.1.1 Middle East and Africa Insulin Aspart Sales by Specification (2017-2028)
10.1.2 Middle East and Africa Insulin Aspart Revenue by Specification (2017-2028)
10.2 Middle East and Africa Insulin Aspart Market Size by Application
10.2.1 Middle East and Africa Insulin Aspart Sales by Application (2017-2028)
10.2.2 Middle East and Africa Insulin Aspart Revenue by Application (2017-2028)
10.3 Middle East and Africa Insulin Aspart Market Size by Country
10.3.1 Middle East and Africa Insulin Aspart Sales by Country (2017-2028)
10.3.2 Middle East and Africa Insulin Aspart Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Toho Pharmaceutical
11.1.1 Toho Pharmaceutical Corporation Information
11.1.2 Toho Pharmaceutical Overview
11.1.3 Toho Pharmaceutical Insulin Aspart Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Toho Pharmaceutical Insulin Aspart Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Toho Pharmaceutical Recent Developments
11.2 Hisun Pharmaceutical
11.2.1 Hisun Pharmaceutical Corporation Information
11.2.2 Hisun Pharmaceutical Overview
11.2.3 Hisun Pharmaceutical Insulin Aspart Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Hisun Pharmaceutical Insulin Aspart Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Hisun Pharmaceutical Recent Developments
11.3 Federal Pharmaceuticals
11.3.1 Federal Pharmaceuticals Corporation Information
11.3.2 Federal Pharmaceuticals Overview
11.3.3 Federal Pharmaceuticals Insulin Aspart Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Federal Pharmaceuticals Insulin Aspart Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Federal Pharmaceuticals Recent Developments
11.4 Ganlee Pharmaceuticals
11.4.1 Ganlee Pharmaceuticals Corporation Information
11.4.2 Ganlee Pharmaceuticals Overview
11.4.3 Ganlee Pharmaceuticals Insulin Aspart Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ganlee Pharmaceuticals Insulin Aspart Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ganlee Pharmaceuticals Recent Developments
11.5 Novo Nordisk
11.5.1 Novo Nordisk Corporation Information
11.5.2 Novo Nordisk Overview
11.5.3 Novo Nordisk Insulin Aspart Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novo Nordisk Insulin Aspart Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novo Nordisk Recent Developments
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Overview
11.6.3 Sanofi Insulin Aspart Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sanofi Insulin Aspart Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sanofi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Insulin Aspart Industry Chain Analysis
12.2 Insulin Aspart Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Insulin Aspart Production Mode & Process
12.4 Insulin Aspart Sales and Marketing
12.4.1 Insulin Aspart Sales Channels
12.4.2 Insulin Aspart Distributors
12.5 Insulin Aspart Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Insulin Aspart Industry Trends
13.2 Insulin Aspart Market Drivers
13.3 Insulin Aspart Market Challenges
13.4 Insulin Aspart Market Restraints
14 Key Findings in The Global Insulin Aspart Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Insulin Aspart Market Size Growth Rate by Specification, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 3Ml: 300 Units
Table 3. Major Manufacturers of 10Ml: 1000 Units
Table 4. Global Insulin Aspart Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Insulin Aspart Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Insulin Aspart Sales by Region (2017-2022) & (Box)
Table 7. Global Insulin Aspart Sales Market Share by Region (2017-2022)
Table 8. Global Insulin Aspart Sales by Region (2023-2028) & (Box)
Table 9. Global Insulin Aspart Sales Market Share by Region (2023-2028)
Table 10. Global Insulin Aspart Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Insulin Aspart Revenue Market Share by Region (2017-2022)
Table 12. Global Insulin Aspart Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Insulin Aspart Revenue Market Share by Region (2023-2028)
Table 14. Global Insulin Aspart Sales by Manufacturers (2017-2022) & (Box)
Table 15. Global Insulin Aspart Sales Share by Manufacturers (2017-2022)
Table 16. Global Insulin Aspart Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Insulin Aspart Revenue Share by Manufacturers (2017-2022)
Table 18. Insulin Aspart Price by Manufacturers (2017-2022) &(US$/Box)
Table 19. Global Insulin Aspart Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Insulin Aspart by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Aspart as of 2021)
Table 21. Insulin Aspart Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Insulin Aspart Product Offered
Table 23. Date of Manufacturers Enter into Insulin Aspart Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Insulin Aspart Sales by Specification (2017-2022) & (Box)
Table 26. Global Insulin Aspart Sales by Specification (2023-2028) & (Box)
Table 27. Global Insulin Aspart Sales Share by Specification (2017-2022)
Table 28. Global Insulin Aspart Sales Share by Specification (2023-2028)
Table 29. Global Insulin Aspart Revenue by Specification (2017-2022) & (US$ Million)
Table 30. Global Insulin Aspart Revenue by Specification (2023-2028) & (US$ Million)
Table 31. Global Insulin Aspart Revenue Share by Specification (2017-2022)
Table 32. Global Insulin Aspart Revenue Share by Specification (2023-2028)
Table 33. Insulin Aspart Price by Specification (2017-2022) & (US$/Box)
Table 34. Global Insulin Aspart Price Forecast by Specification (2023-2028) & (US$/Box)
Table 35. Global Insulin Aspart Sales by Application (2017-2022) & (Box)
Table 36. Global Insulin Aspart Sales by Application (2023-2028) & (Box)
Table 37. Global Insulin Aspart Sales Share by Application (2017-2022)
Table 38. Global Insulin Aspart Sales Share by Application (2023-2028)
Table 39. Global Insulin Aspart Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Insulin Aspart Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Insulin Aspart Revenue Share by Application (2017-2022)
Table 42. Global Insulin Aspart Revenue Share by Application (2023-2028)
Table 43. Insulin Aspart Price by Application (2017-2022) & (US$/Box)
Table 44. Global Insulin Aspart Price Forecast by Application (2023-2028) & (US$/Box)
Table 45. North America Insulin Aspart Sales by Specification (2017-2022) & (Box)
Table 46. North America Insulin Aspart Sales by Specification (2023-2028) & (Box)
Table 47. North America Insulin Aspart Revenue by Specification (2017-2022) & (US$ Million)
Table 48. North America Insulin Aspart Revenue by Specification (2023-2028) & (US$ Million)
Table 49. North America Insulin Aspart Sales by Application (2017-2022) & (Box)
Table 50. North America Insulin Aspart Sales by Application (2023-2028) & (Box)
Table 51. North America Insulin Aspart Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Insulin Aspart Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Insulin Aspart Sales by Country (2017-2022) & (Box)
Table 54. North America Insulin Aspart Sales by Country (2023-2028) & (Box)
Table 55. North America Insulin Aspart Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Insulin Aspart Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Insulin Aspart Sales by Specification (2017-2022) & (Box)
Table 58. Europe Insulin Aspart Sales by Specification (2023-2028) & (Box)
Table 59. Europe Insulin Aspart Revenue by Specification (2017-2022) & (US$ Million)
Table 60. Europe Insulin Aspart Revenue by Specification (2023-2028) & (US$ Million)
Table 61. Europe Insulin Aspart Sales by Application (2017-2022) & (Box)
Table 62. Europe Insulin Aspart Sales by Application (2023-2028) & (Box)
Table 63. Europe Insulin Aspart Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Insulin Aspart Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Insulin Aspart Sales by Country (2017-2022) & (Box)
Table 66. Europe Insulin Aspart Sales by Country (2023-2028) & (Box)
Table 67. Europe Insulin Aspart Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Insulin Aspart Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Insulin Aspart Sales by Specification (2017-2022) & (Box)
Table 70. Asia Pacific Insulin Aspart Sales by Specification (2023-2028) & (Box)
Table 71. Asia Pacific Insulin Aspart Revenue by Specification (2017-2022) & (US$ Million)
Table 72. Asia Pacific Insulin Aspart Revenue by Specification (2023-2028) & (US$ Million)
Table 73. Asia Pacific Insulin Aspart Sales by Application (2017-2022) & (Box)
Table 74. Asia Pacific Insulin Aspart Sales by Application (2023-2028) & (Box)
Table 75. Asia Pacific Insulin Aspart Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Insulin Aspart Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Insulin Aspart Sales by Region (2017-2022) & (Box)
Table 78. Asia Pacific Insulin Aspart Sales by Region (2023-2028) & (Box)
Table 79. Asia Pacific Insulin Aspart Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Insulin Aspart Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Insulin Aspart Sales by Specification (2017-2022) & (Box)
Table 82. Latin America Insulin Aspart Sales by Specification (2023-2028) & (Box)
Table 83. Latin America Insulin Aspart Revenue by Specification (2017-2022) & (US$ Million)
Table 84. Latin America Insulin Aspart Revenue by Specification (2023-2028) & (US$ Million)
Table 85. Latin America Insulin Aspart Sales by Application (2017-2022) & (Box)
Table 86. Latin America Insulin Aspart Sales by Application (2023-2028) & (Box)
Table 87. Latin America Insulin Aspart Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Insulin Aspart Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Insulin Aspart Sales by Country (2017-2022) & (Box)
Table 90. Latin America Insulin Aspart Sales by Country (2023-2028) & (Box)
Table 91. Latin America Insulin Aspart Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Insulin Aspart Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Insulin Aspart Sales by Specification (2017-2022) & (Box)
Table 94. Middle East and Africa Insulin Aspart Sales by Specification (2023-2028) & (Box)
Table 95. Middle East and Africa Insulin Aspart Revenue by Specification (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Insulin Aspart Revenue by Specification (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Insulin Aspart Sales by Application (2017-2022) & (Box)
Table 98. Middle East and Africa Insulin Aspart Sales by Application (2023-2028) & (Box)
Table 99. Middle East and Africa Insulin Aspart Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Insulin Aspart Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Insulin Aspart Sales by Country (2017-2022) & (Box)
Table 102. Middle East and Africa Insulin Aspart Sales by Country (2023-2028) & (Box)
Table 103. Middle East and Africa Insulin Aspart Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Insulin Aspart Revenue by Country (2023-2028) & (US$ Million)
Table 105. Toho Pharmaceutical Corporation Information
Table 106. Toho Pharmaceutical Description and Major Businesses
Table 107. Toho Pharmaceutical Insulin Aspart Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 108. Toho Pharmaceutical Insulin Aspart Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Toho Pharmaceutical Recent Developments
Table 110. Hisun Pharmaceutical Corporation Information
Table 111. Hisun Pharmaceutical Description and Major Businesses
Table 112. Hisun Pharmaceutical Insulin Aspart Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 113. Hisun Pharmaceutical Insulin Aspart Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Hisun Pharmaceutical Recent Developments
Table 115. Federal Pharmaceuticals Corporation Information
Table 116. Federal Pharmaceuticals Description and Major Businesses
Table 117. Federal Pharmaceuticals Insulin Aspart Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 118. Federal Pharmaceuticals Insulin Aspart Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Federal Pharmaceuticals Recent Developments
Table 120. Ganlee Pharmaceuticals Corporation Information
Table 121. Ganlee Pharmaceuticals Description and Major Businesses
Table 122. Ganlee Pharmaceuticals Insulin Aspart Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 123. Ganlee Pharmaceuticals Insulin Aspart Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Ganlee Pharmaceuticals Recent Developments
Table 125. Novo Nordisk Corporation Information
Table 126. Novo Nordisk Description and Major Businesses
Table 127. Novo Nordisk Insulin Aspart Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 128. Novo Nordisk Insulin Aspart Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Novo Nordisk Recent Developments
Table 130. Sanofi Corporation Information
Table 131. Sanofi Description and Major Businesses
Table 132. Sanofi Insulin Aspart Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2017-2022)
Table 133. Sanofi Insulin Aspart Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Sanofi Recent Developments
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Insulin Aspart Distributors List
Table 138. Insulin Aspart Customers List
Table 139. Insulin Aspart Market Trends
Table 140. Insulin Aspart Market Drivers
Table 141. Insulin Aspart Market Challenges
Table 142. Insulin Aspart Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Aspart Product Picture
Figure 2. Global Insulin Aspart Market Share by Specification in 2021 & 2028
Figure 3. 3Ml: 300 Units Product Picture
Figure 4. 10Ml: 1000 Units Product Picture
Figure 5. Global Insulin Aspart Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Insulin Aspart Report Years Considered
Figure 10. Global Insulin Aspart Sales 2017-2028 (Box)
Figure 11. Global Insulin Aspart Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Insulin Aspart Revenue 2017-2028 (US$ Million)
Figure 13. Global Insulin Aspart Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Insulin Aspart Sales Market Share by Region (2017-2022)
Figure 15. Global Insulin Aspart Sales Market Share by Region (2023-2028)
Figure 16. North America Insulin Aspart Sales YoY (2017-2028) & (Box)
Figure 17. North America Insulin Aspart Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Insulin Aspart Sales YoY (2017-2028) & (Box)
Figure 19. Europe Insulin Aspart Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Insulin Aspart Sales YoY (2017-2028) & (Box)
Figure 21. Asia-Pacific Insulin Aspart Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Insulin Aspart Sales YoY (2017-2028) & (Box)
Figure 23. Latin America Insulin Aspart Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Insulin Aspart Sales YoY (2017-2028) & (Box)
Figure 25. Middle East & Africa Insulin Aspart Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Insulin Aspart Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Insulin Aspart in the World: Market Share by Insulin Aspart Revenue in 2021
Figure 28. Global Insulin Aspart Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Insulin Aspart Sales Market Share by Specification (2017-2028)
Figure 30. Global Insulin Aspart Revenue Market Share by Specification (2017-2028)
Figure 31. Global Insulin Aspart Sales Market Share by Application (2017-2028)
Figure 32. Global Insulin Aspart Revenue Market Share by Application (2017-2028)
Figure 33. North America Insulin Aspart Sales Market Share by Specification (2017-2028)
Figure 34. North America Insulin Aspart Revenue Market Share by Specification (2017-2028)
Figure 35. North America Insulin Aspart Sales Market Share by Application (2017-2028)
Figure 36. North America Insulin Aspart Revenue Market Share by Application (2017-2028)
Figure 37. North America Insulin Aspart Sales Share by Country (2017-2028)
Figure 38. North America Insulin Aspart Revenue Share by Country (2017-2028)
Figure 39. United States Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Insulin Aspart Sales Market Share by Specification (2017-2028)
Figure 42. Europe Insulin Aspart Revenue Market Share by Specification (2017-2028)
Figure 43. Europe Insulin Aspart Sales Market Share by Application (2017-2028)
Figure 44. Europe Insulin Aspart Revenue Market Share by Application (2017-2028)
Figure 45. Europe Insulin Aspart Sales Share by Country (2017-2028)
Figure 46. Europe Insulin Aspart Revenue Share by Country (2017-2028)
Figure 47. Germany Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 48. France Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Insulin Aspart Sales Market Share by Specification (2017-2028)
Figure 53. Asia Pacific Insulin Aspart Revenue Market Share by Specification (2017-2028)
Figure 54. Asia Pacific Insulin Aspart Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Insulin Aspart Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Insulin Aspart Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Insulin Aspart Revenue Share by Region (2017-2028)
Figure 58. China Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 61. India Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Insulin Aspart Sales Market Share by Specification (2017-2028)
Figure 68. Latin America Insulin Aspart Revenue Market Share by Specification (2017-2028)
Figure 69. Latin America Insulin Aspart Sales Market Share by Application (2017-2028)
Figure 70. Latin America Insulin Aspart Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Insulin Aspart Sales Share by Country (2017-2028)
Figure 72. Latin America Insulin Aspart Revenue Share by Country (2017-2028)
Figure 73. Mexico Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Insulin Aspart Sales Market Share by Specification (2017-2028)
Figure 77. Middle East and Africa Insulin Aspart Revenue Market Share by Specification (2017-2028)
Figure 78. Middle East and Africa Insulin Aspart Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Insulin Aspart Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Insulin Aspart Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Insulin Aspart Revenue Share by Country (2017-2028)
Figure 82. Turkey Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Insulin Aspart Revenue (2017-2028) & (US$ Million)
Figure 85. Insulin Aspart Value Chain
Figure 86. Insulin Aspart Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed